GEODE CAPITAL MANAGEMENT, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,467,394
+3.5%
2,395,161
+16.6%
0.00%
Q2 2023$2,383,134
-20.1%
2,054,426
+4.0%
0.00%
Q1 2023$2,982,180
+60810.5%
1,974,954
+0.8%
0.00%
-100.0%
Q4 2022$4,896
-99.9%
1,958,442
+7.2%
0.00%0.0%
Q3 2022$7,706,000
+52.4%
1,826,299
+0.8%
0.00%0.0%
Q2 2022$5,057,000
-46.2%
1,812,634
+10.2%
0.00%0.0%
Q1 2022$9,405,000
-39.8%
1,644,360
-3.9%
0.00%
-50.0%
Q4 2021$15,626,000
-9.3%
1,711,608
+6.2%
0.00%0.0%
Q3 2021$17,236,000
-30.1%
1,612,375
+1.4%
0.00%
-33.3%
Q2 2021$24,667,000
+5.6%
1,589,392
+10.3%
0.00%
-25.0%
Q1 2021$23,360,000
-15.4%
1,441,145
+10.5%
0.00%
-20.0%
Q4 2020$27,613,000
+48.2%
1,304,671
+3.8%
0.01%
+25.0%
Q3 2020$18,633,000
-0.1%
1,257,290
-0.9%
0.00%0.0%
Q2 2020$18,655,000
+31.6%
1,268,186
+5.0%
0.00%0.0%
Q1 2020$14,176,000
-73.4%
1,207,511
-46.7%
0.00%
-33.3%
Q4 2019$53,214,000
+211.9%
2,264,520
+145.5%
0.01%
+50.0%
Q3 2019$17,061,000
+2.3%
922,225
+2.8%
0.00%0.0%
Q2 2019$16,676,000
-16.3%
897,080
+10.0%
0.00%
-20.0%
Q1 2019$19,924,000
-48.9%
815,228
-45.7%
0.01%
-16.7%
Q4 2018$38,974,000
+69.9%
1,502,500
+107.3%
0.01%0.0%
Q3 2018$22,940,000
-8.8%
724,821
+11.9%
0.01%
-25.0%
Q2 2018$25,159,000
+91.6%
647,611
+36.1%
0.01%
+100.0%
Q1 2018$13,129,000
+82.5%
475,700
+19.7%
0.00%
+100.0%
Q4 2017$7,193,000
+12.8%
397,456
+0.6%
0.00%0.0%
Q3 2017$6,379,000
+19.1%
395,046
+2.2%
0.00%0.0%
Q2 2017$5,354,000
-0.7%
386,626
+7.5%
0.00%0.0%
Q1 2017$5,394,000
+55.7%
359,640
+35.9%
0.00%0.0%
Q4 2016$3,465,000
-21.1%
264,556
+3.7%
0.00%0.0%
Q3 2016$4,394,000
+11.2%
255,038
+16.5%
0.00%0.0%
Q2 2016$3,952,000
+0.2%
218,988
+5.4%
0.00%0.0%
Q1 2016$3,945,000
-27.9%
207,789
+1.4%
0.00%
-33.3%
Q4 2015$5,469,000
+6.2%
204,881
-2.9%
0.00%0.0%
Q3 2015$5,148,000
-16.6%
211,006
+6.5%
0.00%
-25.0%
Q2 2015$6,171,000
+185.2%
198,050
+33.1%
0.00%
+300.0%
Q1 2015$2,164,000
+71.5%
148,780
+18.6%
0.00%0.0%
Q4 2014$1,262,000
+22.8%
125,484
+1.6%
0.00%0.0%
Q3 2014$1,028,000
-24.0%
123,467
+12.5%
0.00%0.0%
Q2 2014$1,352,000
+56.3%
109,784
+76.4%
0.00%0.0%
Q1 2014$865,00062,2430.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders